AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Green, PJ Warre, R Hayes, PD McNaughton, NCL Medhurst, AD Pangalos, M Duckworth, DM Randall, AD
Citation: Pj. Green et al., Kinetic modification of the alpha(1I) subunit-mediated T-type Ca2+ channelby a human neuronal Ca2+ channel gamma subunit, J PHYSL LON, 533(2), 2001, pp. 467-478

Authors: Meadows, HJ Chapman, CG Duckworth, DM Kelsell, RE Murdock, PR Nasir, S Rennie, G Randall, AD
Citation: Hj. Meadows et al., The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK, BRAIN RES, 892(1), 2001, pp. 94-101

Authors: Bromidge, SM Dabbs, S Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Saunders, DV Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866

Authors: Bromidge, SM Davies, S Duckworth, DM Forbes, IT Jones, GE Jones, J King, FD Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Riley, GJ Trail, B Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870

Authors: Hayes, P Meadows, HJ Gunthorpe, MJ Harries, MH Duckworth, DM Cairns, W Harrison, DC Clarke, CE Ellington, K Prinjha, RK Barton, AJL Medhurst, AD Smith, GD Topp, S Murdock, P Sanger, GJ Terrett, J Jenkins, O Benham, CD Randall, AD Gloger, IS Davis, JB
Citation: P. Hayes et al., Cloning and functional expression of a human orthologue of rat vanilloid receptor-1, PAIN, 88(2), 2000, pp. 205-215

Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gaster, LM Ham, P Jones, GE King, FD Mulholland, KR Saunders, DV Wyman, PA Blaney, FE Clarke, SE Blackburn, TP Holland, V Kennett, GA Lightowler, S Middlemiss, DN Trail, B Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134

Authors: Lovell, PJ Bromidge, SM Dabbs, S Duckworth, DM Forbes, IT Jennings, AJ King, FD Middlemiss, DN Rahman, SK Saunders, DV Collin, LL Hagan, JJ Riley, GJ Thomas, DR
Citation: Pj. Lovell et al., A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970), J MED CHEM, 43(3), 2000, pp. 342-345

Authors: Bromidge, SM Dabbs, S Davies, DT Davies, S Duckworth, DM Forbes, IT Gadre, A Ham, P Jones, GE King, FD Saunders, DV Thewlis, KM Vyas, D Blackburn, TP Holland, V Kennett, GA Riley, GJ Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773
Risultati: 1-8 |